Thymosin Beta 4
Thymosin beta 4 (TB4) is the predominant form of thymosin in our bodies. It has been found in high concentrations in wound tissue and certain blood cells involved in clotting, signifying its important role in the healing process. In fact, recent studies have revealed that the first gene to be up-regulated after an injury is the TB4 gene. As the body begins the recovery process, TB4 aids in the creation of new vessels in the injured area, which carry blood, nutrients, and repairing substances to the site. TB4 also has anti-inflammatory properties, and works to decrease the amount of inflammatory substances, called cytokines. Inflammation plays a large role in many of the symptoms associated with a large number of conditions (i.e., Lyme disease, Chronic Fatigue Syndrome, Fibromyalgia, autoimmune diseases, infections, etc.), making the potential impact of TB4 quite extensive.
The discovery of the role of TB4 in the process of immune regulation has lead to its use as a valuable therapeutic agent. TB4 has been used in the treatment of HIV, AIDS, Influenza, colds, and various infections. It has been utilized in the management of various inflammatory conditions, as well as part of treatment following heart attack due to its cardio and neuro-protective effects.
TB4 is very well tolerated and has not been found to cause any significant side effects. It can be taken on its own or in conjunction with an existing therapy, making it a versatile and valuable drug.